Improved synthesis of 9-(2,3-dideoxy-2-fluoro-β-d-threo-pentofuranosyl)adenine (FddA) using triethylamine trihydrofluoride

[1]  V. Marquez,et al.  The “β-Fluorine Effect” in the Non-Metal Hydride Radical Deoxygenation of Fluorine-Containing Nucleoside Xanthates , 2000, Nucleosides, nucleotides & nucleic acids.

[2]  S. Takamatsu,et al.  Synthesis of 9-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)adenine Bearing a Slectively Removable Protecting Group , 1999 .

[3]  S. Takamatsu,et al.  INTRODUCTION OF A BENZOYL GROUP ONTO RIBOSIDE IN AQUEOUS SOLUTION : ONE-STEP SYNTHESIS OF 6-CHLOROPURINE 2', 3'-DI-O-BENZOYLRIBOSIDE , 1999 .

[4]  V. Marquez,et al.  A new synthetic approach to the clinically useful, anti-HIV-active nucleoside, 9-(2,3-dideoxy-2-fluoro-β-D-threo-pentofuranosyl)adenine (β-FddA). Introduction of a 2′-β-fluoro substituent via inversion of a readily obtainable 2′-α-fluoro isomer , 1998 .

[5]  H. Mitsuya,et al.  In vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-beta-Fluoro-2',3'-dideoxyadenosine , 1997, Antimicrobial agents and chemotherapy.

[6]  D. Mayers,et al.  2′-Fluoro-2′,3′-Dideoxyarabinosyladenine (F-ddA): Activity against Drug-Resistant Human Immunodeficiency Virus Strains and Clades A-E , 1997 .

[7]  R. Davey,et al.  Potent activity of 2'-beta-fluoro-2',3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice , 1996, Antimicrobial agents and chemotherapy.

[8]  G. Haufe.  Triethylamine Trishydrofluoride in Synthesis , 1996 .

[9]  Bruce E. Parker,et al.  Triethylamine poly(hydrogen fluorides) in the synthesis of a fluorinated nucleoside glycon , 1996 .

[10]  Kyoichi A. Watanabe,et al.  Synthesis of 2′-β-fluoro-substituted nucleosides by a direct approach , 1993 .

[11]  C. Chatgilialoglu,et al.  Progress of the Barton-McComble Methodology: From tin hydrides to Silanes , 1993 .

[12]  C. K. Chu,et al.  Nucleosides and Nucleotides as Antitumor and Antiviral Agents , 1993, Springer US.

[13]  Y. Uchida,et al.  A Novel Method for the Synthesis of ddA and F-ddA Via Regioselective 2′-O-Deacetylation of 9-(2,5-DI-O-Acetyl-3-bromo-3-deoxy-β-D-xylofuranosyl)adenine , 1992 .

[14]  Kyoichi A. Watanabe,et al.  A synthesis of 9-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)adenine and -hypoxanthine. An effect of C3'-endo to C2'-endo conformational shift on the reaction course of 2'-hydroxyl group with DAST , 1992 .

[15]  H. Mitsuya,et al.  Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugs. , 1991, Journal of medicinal chemistry.

[16]  B. Nawrot,et al.  Synthesis of 9-(2-Deoxy-2-Fukuoro-β-D- Abinoruranosyl)Hypoxhine. The First Direct Introduction of A 2′-β-Fldoro Substituent in Ppepormed Purine Nucleosides. Studies Directed Toward the Synthesis of 2′-DEOXY-2′-Substituted Arabppmocebosides. 8.1 , 1991 .

[17]  H. Mitsuya,et al.  Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV. , 1990, Journal of medicinal chemistry.

[18]  D. Picq,et al.  Et3N.2HF, a new convenient reagent for nucleophilic fluorine displacement reactions , 1990 .

[19]  E. De Clercq,et al.  Synthesis and anti-HIV activity of various 2'- and 3'-substituted 2',3'-dideoxyadenosines: a structure-activity analysis. , 1987, Journal of medicinal chemistry.

[20]  H. Mitsuya,et al.  2',3'-Dideoxy-2'-fluoro-ara-A. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV). , 1987, Biochemical pharmacology.

[21]  G. B. Brown,et al.  The synthesis of 9-beta-D-ribofuranosylpurine and the identity of nebularine. , 1953, The Journal of biological chemistry.